BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2015 5:11:00 PM | Browse: 989 | Download: 1478
 |
Received |
|
2014-11-20 09:13 |
|
Peer-Review Started |
|
2014-11-20 15:41 |
|
To Make the First Decision |
|
2014-12-12 17:23 |
|
Return for Revision |
|
2014-12-25 17:25 |
|
Revised |
|
2015-03-17 00:00 |
|
Second Decision |
|
2015-07-15 17:23 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2015-07-23 16:54 |
|
Articles in Press |
|
2015-07-23 16:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-08-20 11:16 |
|
Publish the Manuscript Online |
|
2015-08-29 17:10 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Alissa Naqvi, Valérie Giordanengo, Brigitte Dunais, Francine de Salvador-Guillouet, Isabelle Perbost, Jacques Durant, Pascal Pugliese, Aline Joulié, Pierre Marie Roger and Eric Rosenthal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Eric Rosenthal, Professor, Internal Medicine Department, Archet Hospital, Centre Hospitalier Universitaire, 51 Route de Saint-Antoine, 06200 Nice,
France. rosenthal.e@chu-nice.fr
|
| Key Words |
Telaprevir; Boceprevir; Hepatitis C virus-human immunodeficiency virus coinfection; Resistance mutations |
| Core Tip |
Data regarding treatment of hepatitis C virus (HCV) infection with triple combination regimen including interferon/ribavirin and a protease inhibitor (telaprevir or boceprevir) among difficult to treat human immunodeficiency virus (HIV)-HCV co-infected patients are lacking. Most of the patients included in this single-center observational study had already failed a previous dual treatment course and had severe liver fibrosis, one out of six being both cirrhotic and non-responder to prior therapy. More than one of two patients displayed sustained virological response, suggesting that in low-income countries, telaprevir and boceprevir may retain their place among potential treatment strategies in HIV-HCV coinfected patients.
|
| Publish Date |
2015-08-29 17:10 |
| Citation |
Naqvi A, Giordanengo V, Dunais B, de Salvador-Guillouet F, Perbost I, Durant J, Pugliese P, Joulié A, Roger PM, Rosenthal E. Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection. World J Hepatol 2015; 7(18): 2177-2183 |
| URL |
http://www.wjgnet.com/1948-5182/full/v7/i18/2177.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v7.i18.2177 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
